glp-1 obesity drug news october 2025 Market Size to Hit USD 66.57 Billion by 2035 7 things to know about

It has attracted significant, sustained attention in in-vitro research focused intensely on connective tissue, skeletal muscle fibers, tendons, ligaments, and highly specialized gastrointestinal tissue models

Unlike saline-brain suspension inoculated mice (which did not differ from virus-suspension inoculated saline treated mice), no disease symptoms or death was observed in NaBPC157-brain suspension inoculated mice

The Effect of Pentadecapeptide BPC 157 on Hippocampal Ischemia/Reperfusion Injuries in Rats

The retrospective cohort study by Orandi et al., recently published in The Lancet Diabetes & Endocrinology , offers compelling evidence on the effectiveness and safety of glucagon-like peptide-1 (GLP-1) receptor agonists in kidney transplant recipients with pre-existing type 2 diabetes (1)

Semaglutide is a prescription-only drug, so advertising it directly to the public is very restricted